Pharmacotherapy of COPD in Central and Eastern Europe - The POPE study

Ruzena Tkacova (Kosice, Slovakia), Ruzena Tkacova, Jan Svancara, Vladimir Koblizek, Attila Somfay, Branislava Milenkovic, Adam Barczyk, Kirill Zykov, Neven Tudoric, Kosta Kostov, Jurij Sorli, Alvils Krams, Zuzana Zbozinkova, Marc Miravitlles, Arschang Valipour

Source: International Congress 2016 – In-patient and out-patient COPD management
Session: In-patient and out-patient COPD management
Session type: Poster Discussion
Number: 556
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Ruzena Tkacova (Kosice, Slovakia), Ruzena Tkacova, Jan Svancara, Vladimir Koblizek, Attila Somfay, Branislava Milenkovic, Adam Barczyk, Kirill Zykov, Neven Tudoric, Kosta Kostov, Jurij Sorli, Alvils Krams, Zuzana Zbozinkova, Marc Miravitlles, Arschang Valipour. Pharmacotherapy of COPD in Central and Eastern Europe - The POPE study. Eur Respir J 2016; 48: Suppl. 60, 556

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Epidemiology of COPD in North America and Europe: Results from a systematic literature review
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Year: 2013


Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study
Source: Eur Respir J, 49 (5) 1601446; 10.1183/13993003.01446-2016
Year: 2017




LATE-BREAKING ABSTRACT: Phenotypes of COPD in central and Eastern Europe - The POPE study
Source: International Congress 2015 – COPD: interesting notes
Year: 2015


Ethnicity and COPD in South London - is there less COPD in the black population?
Source: International Congress 2014 – Management of COPD in primary care
Year: 2014

GOLD 2017 on the way to a phenotypic approach? Analysis from the Phenotypes of COPD in Central and Eastern Europe (POPE) Cohort
Source: Eur Respir J , 49 (4)  1602518; DOI: 10.1183/13993003.02518-2016
Year: 2017



Respiratory symptoms, bronchitis and asthma in children of Central and Eastern Europe
Source: Eur Respir J 2002; 20: 890-898
Year: 2002



Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey
Source: Eur Respir J 2002; 20: 799-805
Year: 2002



Evaluation of respiratory symptoms in COPD patients from seven Latin America countries: The LASSYC Study
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017

Geographical variation of prevalence, and under-diagnosis of COPD in urban and rural communities of China: Finding from China Kadoorie Biobank of 0.5M people
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Year: 2013


LATE-BREAKING ABSTRACT: The use of benzodiazepines in COPD: A population-based study of Norway
Source: Annual Congress 2013 –Highlights in epidemiology of respiratory disease
Year: 2013

The confronting COPD survey in Central and Eastern Europe
Source: Eur Respir J 2005; 26: Suppl. 49, 296s
Year: 2005

Gender differences in long-term outcomes of COPD: A population based study in Italy
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014


COPD prevalence in Argentina: The EPOC.AR study
Source: International Congress 2016 – Prevalence of obstructive airway diseases, methods of diagnosis, and lung function testing
Year: 2016

Prevalence of chronic bronchitis in the Middle-East and North Africa: Interim results of the BREATHE study
Source: Annual Congress 2011 - Respiratory epidemiology: prevalence, incidence and remission
Year: 2011


The prevalence of COPD in Annaba, Algeria: Results of the BOLD study
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014


The disease burden of mild asthmatics in China
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016


Mortality rates in individuals with asthma, COPD and ACOS in a large population-based cohort: Is gender important?
Source: International Congress 2016 – Asthma, COPD, and ACOS: physical activity, dietary aspects, and diseases burden
Year: 2016


Risk of cardiovascular events following COPD hospitalisation: Findings from the China Kadoorie Biobank cohort study
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015

Mortality after COPD-exacerbations: Learning from epidemiology
Source: International Congress 2014 – Clinical presentations
Year: 2014

The Italian registry for severe/uncontrolled asthma
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016